GLP-1 weight loss programs utilize semaglutide-based medications, like Ozempic and Wegovy, to help manage body weight and improve health
Leerink Partners analyst David Risinger said he expects volume growth of the companies' obesity drug prescriptions to start picking up in July, with "rapid adoption" over the second half of the year
12,58,59 In a comprehensive systematic review and meta-analysis including more than 34,000 patients with T2DM, semaglutide therapy was not associated with an increased risk of pancreatitis
Obesity can also cause a series of other diseases known as metabolic syndromes, as obesity is an amalgamation of many body dysfunctions
In 2023, NICE issued similar guidance for semaglutide, although this time, the duration of treatment was restricted to a maximum of two years and the drug could only be provided within a specialist weight management service